Second Sight Medical Products Inc


Second Sight Medical Products Inc’s (EYES) Argus II Retinal Prosthesis System Implanted in First Patient in Asia; Shares Rise Over 30%

Second Sight Medical Products Inc (NASDAQ:EYES) announced that the Argus® II Retinal Prosthesis System (Argus II) has been implanted in the first patient …

Company Update (NASDAQ:EYES): Second Sight Medical Products Inc Announces Positive Reimbursement Renewal Decision in Germany

Second Sight Medical Products Inc (NASDAQ:EYES) announced that the German Institute for the Hospital Remuneration System (InEK) has renewed Status 1 (full approval) …

Stock Update (NASDAQ:EYES): Second Sight Medical Products Inc Announces Rights Offering; Shares Dip 4%

Second Sight Medical Products Inc (NASDAQ:EYES) announced it filed a registration statement on Form S-1 with the Securities and Exchange Commission or a …

Company Update (NASDAQ:EYES): Second Sight Medical Products Inc Receives Funding from the UK Government for Argus II “Bionic Eye”

Second Sight Medical Products Inc (NASDAQ:EYES) announced, following a positive recommendation from advisors to the UK Government’s healthcare funding authority for specialized services …

Stock Update (NASDAQ:EYES): Second Sight Medical Products Inc Announces Successful Implantation and Activation of Wireless Visual Cortical Stimulator in First Human Subject

Second Sight Medical Products Inc (NASDAQ:EYES) announced the first successful implantation and activation of a wireless visual cortical stimulator in a human subject, providing …

Rodman & Renshaw Comments on Second Sight Medical Products Inc (EYES) Following Positive Five-Year Data for Argus II Retinal Prosthesis System

In a research report released Friday, Rodman & Renshaw analyst Amit Dayal reiterated a Buy rating on shares of Second Sight Medical Products Inc (NASDAQ:EYES), …

Second Sight Medical Products Inc (EYES) From A Bearish Perspective

by Sonya Colberg Two eye-opening announcements over the last couple of days jumped shares of Second Sight Medical Products Inc (NASDAQ:EYES) above $6 …

Stock Update (NASDAQ:EYES): Second Sight Medical Products Inc to Announce Five-Year Data from Argus II Clinical Trial Program

Second Sight Medical Products Inc (NASDAQ:EYES), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, announced …

Company Update (NASDAQ:EYES): Second Sight Medical Products, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Second Sight Medical Products Inc (NASDAQ:EYES), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts